Dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

Catalog No. :
ACXABM513
CAS No. :
43067-01-2
Molecular Formula :
C17H18ClNO4
Molecular Weight :
335.79

IUPAC Name:dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

Dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg98%$53.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
IUPAC Namedimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
MDL No.MFCD00194047
Molecular FormulaC17H18ClNO4
Molecular Weight335.79
SMILESO=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC=C2Cl)OC
InChI KeyREIGLQUFMMOAFU-UHFFFAOYSA-N
SynonymAmlodipine besilate impurity G | Oprea1_609948 | 3,5-PYRIDINEDICARBOXYLIC ACID, 4-(2-CHLOROPHENYL)-1,4-DIHYDRO-2,6-DIMETHYL-, 3,5-DIMETHYL ESTER | FT-0667343 | STK387362 | EU-0035198 | SCHEMBL3035724 | SR-01000403200-1 | REIGLQUFMMOAFU-UHFFFAOYSA-N | SR-0
CAS No.43067-01-2
PubChem CID737062

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXABM513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXABM513 route product structure diagram
    ACXABM51343067-01-2
Inquiry

2. ACXABM513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXABM513 route product structure diagram
    ACXABM51343067-01-2
Inquiry

Comments (0)